Mobitz type II second-degree heart block is typically treated initially with which intervention?

Mobitz type II second-degree heart block is typically treated initially with which intervention?

• A. Temporary transcutaneous pacing
• B. Intravenous atropine
• C. Immediate defibrillation
• D. Oral beta-blocker

Answer: (A)

Mobitz type II second-degree block is an infranodal conduction problem with a real risk of dropping into complete heart block. The best initial management is temporary transcutaneous pacing to quickly maintain an adequate heart rate and perfusion while arranging definitive therapy (usually temporary transvenous pacing or a permanent pacemaker). This approach addresses the fundamental issue—insufficient automaticity and impulse transmission below the AV node—without relying on drugs that won’t fix the underlying block. Intravenous atropine can help when the issue is primarily at the AV node, but it’s unreliable for Mobitz II because the block is below the AV node. It may transiently increase rate in some patients, but it doesn’t address the fixed conduction defect and can give a false sense of improvement. Immediate defibrillation is reserved for pulseless rhythms such as ventricular fibrillation or pulseless VT, not for stable or symptomatic bradycardia from Mobitz II. An oral beta-blocker would worsen bradycardia and conduction slowing, making the situation worse rather than better. So, starting with temporary pacing buys time and stabilizes the patient while definitive pacing therapy is arranged.

Mobitz type II second-degree block is an infranodal conduction problem with a real risk of dropping into complete heart block. The best initial management is temporary transcutaneous pacing to quickly maintain an adequate heart rate and perfusion while arranging definitive therapy (usually temporary transvenous pacing or a permanent pacemaker). This approach addresses the fundamental issue—insufficient automaticity and impulse transmission below the AV node—without relying on drugs that won’t fix the underlying block.

Intravenous atropine can help when the issue is primarily at the AV node, but it’s unreliable for Mobitz II because the block is below the AV node. It may transiently increase rate in some patients, but it doesn’t address the fixed conduction defect and can give a false sense of improvement. Immediate defibrillation is reserved for pulseless rhythms such as ventricular fibrillation or pulseless VT, not for stable or symptomatic bradycardia from Mobitz II. An oral beta-blocker would worsen bradycardia and conduction slowing, making the situation worse rather than better.

So, starting with temporary pacing buys time and stabilizes the patient while definitive pacing therapy is arranged.